Stryker (SYK) Operating Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.32% |
| Dec 31, 2025 | 19.22% |
| Sep 30, 2025 | 5.73% |
| Jun 30, 2025 | 124.99% |
| Mar 31, 2025 | 5.68% |
| Dec 31, 2024 | -9.25% |
| Sep 30, 2024 | 11.56% |
| Jun 30, 2024 | 11.39% |
| Mar 31, 2024 | 12.98% |
| Dec 31, 2023 | 12.49% |
| Sep 30, 2023 | 10.08% |
| Jun 30, 2023 | 7.51% |
| Mar 31, 2023 | 4.46% |
| Dec 31, 2022 | 2.66% |
| Sep 30, 2022 | 9.01% |
| Jun 30, 2022 | 8.99% |
| Mar 31, 2022 | -4.27% |
| Dec 31, 2021 | 4.10% |
| Sep 30, 2021 | 3.38% |
| Jun 30, 2021 | 7.92% |
| Mar 31, 2021 | -2.43% |
| Dec 31, 2020 | 2.94% |
| Sep 30, 2020 | 17.84% |
| Jun 30, 2020 | -15.40% |
| Mar 31, 2020 | 9.36% |
| Dec 31, 2019 | 15.07% |
| Sep 30, 2019 | 6.89% |
| Jun 30, 2019 | 25.49% |
| Mar 31, 2019 | 32.15% |
| Dec 31, 2018 | 10.17% |
| Sep 30, 2018 | 30.88% |
| Jun 30, 2018 | 18.30% |
| Mar 31, 2018 | 8.89% |
| Dec 31, 2017 | 14.05% |
| Sep 30, 2017 | 3.13% |
| Jun 30, 2017 | 2.44% |
| Mar 31, 2017 | 3.16% |
| Dec 31, 2016 | 9.90% |
| Sep 30, 2016 | 1.82% |
| Jun 30, 2016 | 4.51% |
| Mar 31, 2016 | 4.18% |
| Dec 31, 2015 | 10.92% |
| Sep 30, 2015 | -4.30% |
| Jun 30, 2015 | -0.87% |
| Mar 31, 2015 | -1.88% |
| Dec 31, 2014 | -1.84% |
| Sep 30, 2014 | 7.64% |
| Jun 30, 2014 | -12.76% |
| Mar 31, 2014 | -19.15% |